DAX24.059 -0,7%Est505.719 -0,6%MSCI World4.343 -0,1%Top 10 Crypto11,51 +2,1%Nas23.016 -0,2%Bitcoin73.944 +0,6%Euro1,1784 +0,3%Öl58,95 -2,3%Gold4.330 +0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 DroneShield A2DMAA Lufthansa 823212 Tesla A1CX3T TUI TUAG50 Bayer BAY001 Deutsche Telekom 555750 Siemens Energy ENER6Y RENK RENK73 BASF BASF11 Volkswagen (VW) vz. 766403 Mercedes-Benz Group (ex Daimler) 710000 Allianz 840400 Novo Nordisk A3EU6F
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schwächer -- Wall Street stabil -- DroneShield erhält Großauftrag aus Europa -- Ford mit Riesen-Abschreibung für E-Auto-Schwenk - Rüstungsaktien, Bayer, ServiceNow, Palantir im Fokus
Top News
Novo Nordisk-Aktie dennoch im Plus: Neue Sammelklage wegen Ozempic & Co. in den USA Novo Nordisk-Aktie dennoch im Plus: Neue Sammelklage wegen Ozempic & Co. in den USA
Emerging Markets: Warum ein Investment in Schwellenländer langfristig eine schlaue Idee sein kann Emerging Markets: Warum ein Investment in Schwellenländer langfristig eine schlaue Idee sein kann
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
US-Aktien als Basis für langfristiges Wachstum? Mit diesem ETF von Amundi erhältst du Zugang zu den größten Unternehmen der Welt.

Bio-Techne Aktie

Kaufen
Verkaufen
Bio-Techne Aktien-Sparplan
48,80 EUR -0,60 EUR -1,21 %
FSE
57,16 USD -1,54 USD -2,62 %
BTT
Bio-Techne jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.7,76 Mrd. EUR

KGV112,02Div. Rendite0,62%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA12ENG

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS09073M1045

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTECH

Bio-Techne Aktien News

DatumMeistgelesen
PR NewswireBio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology
PR NewswireBio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis
PR NewswireBio-Techne to Present at Upcoming Investor Conferences
Wer­bungBio-Techne-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireBio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
PR NewswireBio-Techne to Present at Upcoming Investor Conferences
PR NewswireBIO-TECHNE DECLARES DIVIDEND
PR NewswireBio-Techne Releases First Quarter Fiscal 2026 Results
PR NewswireAI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients
PR NewswireScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics
PR NewswireBio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
PR NewswireBio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
PR NewswireBio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
PR NewswireBio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
PR NewswireBio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report
PR NewswireEvolve Announces September 2025 Distributions for Certain Evolve Funds
PR NewswireScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
PR NewswireBio-Techne to Present at Upcoming Investor Conferences
PR NewswireScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
PR NewswireBio-Techne Releases Fourth Quarter Fiscal 2025 Results
PR NewswireBIO-TECHNE DECLARES DIVIDEND
PR NewswireBio-Techne Announces Exosome Diagnostics Divestiture
PR NewswireScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine
PR NewswireScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering
PR NewswireEvolve Announces July 2025 Distributions for Certain Evolve Funds
PR NewswireBio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
PR NewswireBio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
PR NewswireBio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
PR NewswireBio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
PR NewswireEvolve Announces June 2025 Distributions for Certain Evolve Funds
PR NewswireScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
PR NewswireBio-Techne to Present at Investor Conferences
PR NewswireEvolve Announces May 2025 Distributions for Certain Evolve Funds
PR NewswireScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
PR NewswireBio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
PR NewswireKytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
PR NewswireBio-Techne to Present at the BofA Securities 2025 Health Care Conference
PR NewswireBIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
PR NewswireBIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
PR NewswireScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
PR NewswireScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy

Bio-Techne News

Bio-Techne News: auf dieser Seite finden Sie alle Bio-Techne News und Nachrichten zur Bio-Techne Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Bio-Techne News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Bio-Techne News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.